Artur Isaev holds MD from Rostov State Medical University (1994) and MBA from Moscow International Business School MIRBIS (1998). From 1994 to 1999 Artur Isaev headed an investment-brokerage company, from 1999 to 2003 he was a CEO of Mauer-Audit & Partners auditing and consulting group. Among other things, he was a co-investor in SMI-link project on the base of which Yandex. Traffic Jams internet service was created in Russia. In 2003 Artur Isaev founded Human Stem Cells Institute – a Russian biotech company, and in 2004 HSCI opened Gemabank® – one of Russia’s first cord blood banks, nowadays the largest family cord blood stem cell bank in Russia and CIS. In 2011 HSCI initiated and became a co-investor in SynBio – a long-term multilateral project to create new unique medicines (first-in-class and BioBetters). The SynBio project unites Russian and international biopharm companies, including Pharmsynthez and Xenetic Biosciences, and is supported by an investment from RUSNANO (a Russian state-owned fund for supporting nanotechnologies). Artur Isaev is a co-founder of IPOboard. He is the Winner of the Entrepreneur of the Year 2012 Award in hi-tech in Russia conducted by Ernst & Young.

His research interests include Tissue engineering, Gene therapy and DNA repair,Development of Diagnostic PCR panels, Therapeutic Angiogenesis